Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Non-Current Assets (2018 - 2026)

Profound Medical has reported Non-Current Assets over the past 8 years, most recently at $1.4 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 18.56% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $4.0 million, down 34.12%, while the annual FY2025 figure was $1.4 million, 18.56% up from the prior year.
  • Non-Current Assets for Q4 2025 was $1.4 million at Profound Medical, up from $781000.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $9.6 million in Q4 2021 and troughed at -$70.7 billion in Q1 2022.
  • A 5-year average of -$6.8 billion and a median of $1.9 million in 2024 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: surged 183317.26% in 2021 and later plummeted 75.16% in 2022.
  • Year by year, Non-Current Assets stood at $9.6 million in 2021, then plummeted by 75.16% to $2.4 million in 2022, then dropped by 14.06% to $2.1 million in 2023, then tumbled by 43.25% to $1.2 million in 2024, then grew by 18.56% to $1.4 million in 2025.
  • Business Quant data shows Non-Current Assets for PROF at $1.4 million in Q4 2025, $781000.0 in Q3 2025, and $857000.0 in Q2 2025.